1. Home
  2. NG vs ADPT Comparison

NG vs ADPT Comparison

Compare NG & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NG
  • ADPT
  • Stock Information
  • Founded
  • NG 1984
  • ADPT 2009
  • Country
  • NG Canada
  • ADPT United States
  • Employees
  • NG N/A
  • ADPT N/A
  • Industry
  • NG Precious Metals
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NG Basic Materials
  • ADPT Health Care
  • Exchange
  • NG Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • NG 940.4M
  • ADPT 1.1B
  • IPO Year
  • NG N/A
  • ADPT 2019
  • Fundamental
  • Price
  • NG $2.98
  • ADPT $7.33
  • Analyst Decision
  • NG
  • ADPT Strong Buy
  • Analyst Count
  • NG 0
  • ADPT 5
  • Target Price
  • NG N/A
  • ADPT $9.40
  • AVG Volume (30 Days)
  • NG 3.2M
  • ADPT 2.4M
  • Earning Date
  • NG 04-01-2025
  • ADPT 05-01-2025
  • Dividend Yield
  • NG N/A
  • ADPT N/A
  • EPS Growth
  • NG N/A
  • ADPT N/A
  • EPS
  • NG N/A
  • ADPT N/A
  • Revenue
  • NG N/A
  • ADPT $178,957,000.00
  • Revenue This Year
  • NG N/A
  • ADPT $21.20
  • Revenue Next Year
  • NG N/A
  • ADPT $22.06
  • P/E Ratio
  • NG N/A
  • ADPT N/A
  • Revenue Growth
  • NG N/A
  • ADPT 5.10
  • 52 Week Low
  • NG $2.26
  • ADPT $2.28
  • 52 Week High
  • NG $4.88
  • ADPT $9.01
  • Technical
  • Relative Strength Index (RSI)
  • NG 51.81
  • ADPT 43.95
  • Support Level
  • NG $2.80
  • ADPT $7.38
  • Resistance Level
  • NG $3.10
  • ADPT $8.30
  • Average True Range (ATR)
  • NG 0.22
  • ADPT 0.75
  • MACD
  • NG 0.04
  • ADPT -0.04
  • Stochastic Oscillator
  • NG 83.72
  • ADPT 33.85

About NG Novagold Resources Inc.

Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other presious metals.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: